Stringent quality and process control is essential to monitor critical parameters, from cellular starting material collection through cell therapy manufacturing, and these laborious tests are challenging to standardize. The ACCELLIX™ Automated Cell Phenotyping Platform eliminates these limitations and automates your entire testing workflow, from sample preparation to data analysis, generating rapid cell phenotyping results directly in the collection site and/or manufacturing suite.

The ACCELLIX™ Platform has the potential to improve cell therapy QC efficiency by providing a simple and rapid workflow that minimizes process variability and subjective data analysis.

Bring simplicity and automation to Cell & Gene Therapy manufacturing through advanced technologies that enhance quality, safety and efficiency; to achieve faster product release.